Announce Date | 02/03/2025 |
EPS Normalized Actual | $127.52 (Beat by $126.92) |
EPS GAAP Actual | $127.52 (Beat by $126.92) |
Revenue Actual | $590.092B |
Revenue Surprise | Beat by $590092M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.99 |
EPS GAAP Estimate | $0.99 |
Revenue Estimate | $0.6401B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.11 | 6.07 | 4.01317 | 4.18651 | 1 |
Dec 2028 | 3.7 | 6.75 | 3.6411 | 3.74205 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 127.52 | 126.595 | 590.092B | -5.99% | 589466.48M |
FQ3 2024 (Sep 2024) | 2691.01 | 2690.0575 | 1857.37B | 65.73% | 1856734.75M |
FQ2 2024 (Jun 2024) | 0.78 | -0.56259 | 0.59335B | -8.17% | -520.56M |
FQ1 2024 (Mar 2024) | 1.24 | -0.33645 | 0.651697B | -101622.43% | -105.53M |
FQ4 2023 (Dec 2023) | 0.0009 | 0.0009 | 625.422B | 100% | 625422M |
FQ3 2023 (Sep 2023) | 1209.03 | 1209.03 | 636.521B | 99.9% | 636521M |
FQ2 2023 (Jun 2023) | 1.3 | 1.3 | 0.641836B | 99.9% | 641.84M |
FQ1 2023 (Mar 2023) | 0 | 0 | 662.922B | 100% | 662922M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.99
Consensus Revenue Estimates
0.6401B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 0.81 | -- | 0.79606 | 0.83242 | 1 |
FQ2 2026 (Jun 2026) | 0.77 | -- | 0.75674 | 0.79131 | 1 |
FQ1 2026 (Mar 2026) | 0.79 | -- | 0.7764 | 0.81186 | 1 |
FQ4 2025 (Oct 2025) | 1.08 | -11707.41 | 1.05166 | 1.10525 | 1 |
FQ3 2025 (Jul 2025) | 0.97 | -277323.71 | 0.94454 | 0.99268 | 1 |
FQ2 2025 (Jun 2025) | 0.99 | 21.21 | 0.96645 | 1.00593 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 0.62B | -- | 0.61B | 0.64B | 1 |
FQ2 2026 (Jun 2026) | 0.58B | -- | 0.58B | 0.6B | 1 |
FQ1 2026 (Mar 2026) | 0.59B | -- | 0.58B | 0.6B | 1 |
FQ4 2025 (Oct 2025) | 0.65B | -90141.93 | 0.64B | 0.67B | 0 |
FQ3 2025 (Jul 2025) | 0.64B | -291664.06 | 0.62B | 0.65B | 0 |
FQ2 2025 (Jun 2025) | 0.64B | 7.3 | 0.63B | 0.65B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.925 | 127.52 | 126.595 | 99.27% |
FQ3 2024 (Sep 2024) | 0.9525 | 2691.01 | 2690.0575 | 99.96% |
FQ2 2024 (Jun 2024) | 1.34259 | 0.78 | -0.56259 | -72.13% |
FQ1 2024 (Mar 2024) | 1.57645 | 1.24 | -0.33645 | -27.13% |
FQ4 2023 (Dec 2023) | 0.0009 | 0.0009 | 100% | |
FQ3 2023 (Sep 2023) | 1209.03 | 1209.03 | 100% | |
FQ2 2023 (Jun 2023) | 1.3 | 1.3 | 100% | |
FQ1 2023 (Mar 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0.63B | $590.09B | $589466.48M | 99.89% |
FQ3 2024 (Sep 2024) | $0.64B | $1857.37B | $1856734.75M | 99.97% |
FQ2 2024 (Jun 2024) | $1.11B | $0.59B | $-520.56M | -87.73% |
FQ1 2024 (Mar 2024) | $0.76B | $0.65B | $-105.53M | -16.19% |
FQ4 2023 (Dec 2023) | $0B | $625.42B | $625422M | 100% |
FQ3 2023 (Sep 2023) | $0B | $636.52B | $636521M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.64B | $641.84M | 100% |
FQ1 2023 (Mar 2023) | $0B | $662.92B | $662922M | 100% |